Equities Research Analysts’ New Coverage for February 27th (BBU, COST, JAZZ, NFLX, NGNE, PLTR, PLYX, PTHS, RVMD, TGT)

Equities Research Analysts’ new coverage for Friday, February 27th:

Canadian Imperial Bank of Commerce assumed coverage on shares of Brookfield Business Partners (NYSE:BBU). They issued a sector outperform rating and a $44.00 target price on the stock.

Bank of America Corporation initiated coverage on shares of Costco Wholesale (NASDAQ:COST). They issued a buy rating and a $1,185.00 price target on the stock.

Barclays PLC assumed coverage on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ). They issued an overweight rating and a $224.00 target price on the stock.

Evercore Inc initiated coverage on shares of Netflix (NASDAQ:NFLX). They issued an outperform rating and a $115.00 target price on the stock.

Canaccord Genuity Group Inc. began coverage on shares of Neurogene (NASDAQ:NGNE). The firm issued a buy rating and a $200.00 price target on the stock.

Rosenblatt Securities assumed coverage on shares of Palantir Technologies (NASDAQ:PLTR). Rosenblatt Securities issued a buy rating and a $150.00 target price on the stock.

Maxim Group initiated coverage on shares of Polaryx Therapeutics (NASDAQ:PLYX). They issued a buy rating and a $10.00 target price on the stock.

Piper Sandler assumed coverage on shares of Pelthos Therapeutics (NYSEAMERICAN:PTHS). The firm issued an overweight rating and a $48.00 price target on the stock.

UBS Group AG assumed coverage on shares of Revolution Medicines (NASDAQ:RVMD). UBS Group AG issued a buy rating on the stock.

Bank of America Corporation began coverage on shares of Target (NYSE:TGT). They issued an underperform rating and a $103.00 target price on the stock.

Bank of America Corporation assumed coverage on shares of Walmart (NASDAQ:WMT). They issued a buy rating and a $150.00 target price on the stock.